# Improving Hepatitis C Treatment in Injection Drug Users

> **NCT00148031** · PHASE4 · COMPLETED · sponsor: **State University of New York - Upstate Medical University** · enrollment: 111 (actual)

## Conditions studied

- Hepatitis C
- Liver Diseases
- Drug Abuse
- Alcoholism

## Interventions

- **DRUG:** Pegylated Interferon and Ribavirin
- **BEHAVIORAL:** Psychosocial
- **BEHAVIORAL:** On-site (MMT Clinic) HCV evaluation and treatment
- **BEHAVIORAL:** Off-site HCV evaluation and treatment

## Key facts

- **NCT ID:** NCT00148031
- **Lead sponsor:** State University of New York - Upstate Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2013-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00148031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00148031, "Improving Hepatitis C Treatment in Injection Drug Users". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00148031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*